Neuromod Devices is an innovative medical technology company dedicated to advancing the field of neuromodulation. With a shared belief in the cutting-edge potential of this branch of medicine, we named ourselves Neuromod. Our mission is to develop and deliver treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions worldwide.

At Neuromod, we are focused on empowering patients to take control of their own treatment. We design products that seamlessly integrate into modern lifestyles, providing targeted therapies that improve quality of life. Our flagship product, the Lenire® device, utilizes our patented bimodal neuromodulation technology.

It has received FDA De Novo Grant approval for the treatment of tinnitus, a condition affecting 10% of adults and commonly known as ringing in the ears. Lenire® is the first device of its kind to receive this prestigious approval in the United States. We are committed to stimulating progress in the field of neuromodulation through the design, clinical validation, and commercialization of our technologies.

By collaborating with leading scientists and clinicians, we conduct extensive trials at renowned clinical sites to build a strong evidence base for our interventions. Join us on our journey as we continue to stimulate innovation and excellence in the field of neuromodulation